Association of lactate dehydrogenase with mortality in incident hemodialysis patients
- PMID: 33367881
 - PMCID: PMC8599773
 - DOI: 10.1093/ndt/gfaa277
 
Association of lactate dehydrogenase with mortality in incident hemodialysis patients
Abstract
Background: Lactate dehydrogenase (LDH) plays a role in the glucose metabolism of the human body. Higher LDH levels have been linked to mortality in various cancer types; however, the relationship between LDH and survival in incident hemodialysis (HD) patients has not yet been examined. We hypothesized that higher LDH level is associated with higher death risk in these patients.
Methods: We examined the association of baseline and time-varying serum LDH with all-cause, cardiovascular and infection-related mortality among 109 632 adult incident HD patients receiving care from a large dialysis organization in the USA during January 2007 to December 2011. Baseline and time-varying survival models were adjusted for demographic variables and available clinical and laboratory surrogates of malnutrition-inflammation complex syndrome.
Results: There was a linear association between baseline serum LDH levels and all-cause, cardiovascular and infection-related mortality in both baseline and time-varying models, except for time-varying infection-related mortality. Adjustment for markers of inflammation and malnutrition attenuated the association in all models. In fully adjusted models, baseline LDH levels ≥360 U/L were associated with the highest risk of all-cause mortality (hazard ratios = 1.19, 95% confidence interval 1.14-1.25). In time-varying models, LDH >280 U/L was associated with higher death risk in all three hierarchical models for all-cause and cardiovascular mortality.
Conclusions: Higher LDH level >280 U/L was incrementally associated with higher all-cause and cardiovascular mortality in incident dialysis patients, whereas LDH <240 U/L was associated with better survival. These findings suggest that the assessment of metabolic functions and monitoring for comorbidities may confer survival benefit to dialysis patients.
Keywords: all-cause mortality; end-stage renal disease; hemodialysis; lactate dehydrogenase.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Jurisic V, Radenkovic S, Konjevic G.. The actual role of LDH as tumor marker, biochemical and clinical aspects. Adv Exp Med Biol 2015; 867: 115–124 - PubMed
 
 - 
    
- Rossello X, Hall AR, Bell RM. et al. Characterization of the Langendorff perfused isolated mouse heart model of global ischemia-reperfusion injury: Impact of ischemia and reperfusion length on infarct size and LDH release. J Cardiovasc Pharmacol Ther 2016; 21: 286–295 - PubMed
 
 - 
    
- Erez A, Shental O, Tchebiner JZ. et al. Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients. Isr Med Assoc J 2014; 16: 439–443 - PubMed
 
 - 
    
- Hernandez-Cardenas CM, Serna-Secundino H, Garcia-Olazaran JG. et al. Acute respiratory distress syndrome secondary to influenza A(H1N1)pdm09: Clinical characteristics and mortality predictors. Rev Invest Clin 2016; 68: 235–244 - PubMed
 
 - 
    
- Drent M, Cobben NA, Henderson RF. et al. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996; 9: 1736–1742 - PubMed
 
 
